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The ETS family transcription factor PU.1 is essential for the development of several blood lineages, including T cells,
but its function in intrathymic T-cell precursors has been poorly defined. In the thymus, high PU.1 expression
persists throughmultiple cell divisions in early stages but then falls sharply duringT-cell lineage commitment. PU.1
silencing is critical for T-cell commitment, but it has remained unknown how PU.1 activities could contribute
positively to T-cell development. Herewe employed conditional knockout andmodified antagonist PU.1 constructs
to perturb PU.1 function stage-specifically in early T cells. We show that PU.1 is needed for full proliferation,
restricting access to some non-T fates, and controlling the timing of T-cell developmental progression such that
removal or antagonism of endogenous PU.1 allows precocious access to T-cell differentiation. Dominant-negative
effects reveal that this repression by PU.1 is mediated indirectly. Genome-wide transcriptome analysis identifies
novel targets of PU.1 positive and negative regulation affecting progenitor cell signaling and cell biology and indi-
cating distinct regulatory effects on different subsets of progenitor cell transcription factors. Thus, in addition to
supporting early T-cell proliferation, PU.1 regulates the timing of activation of the core T-lineage developmental
program.
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The hematopoietic transcription factor PU.1 plays a cen-
tral role in lymphoid and myeloid cell fates. PU.1-null
animals die before birth due to hematopoietic failure, and
conditional knockout PU.1 hematopoietic stem cells
(HSCs) fail to contribute to lymphoid, myeloid, or den-
dritic cell lineages (Scott et al. 1994; McKercher et al.
1996; Dakic et al. 2005; Iwasaki et al. 2005; Nutt et al.
2005; Carotta et al. 2010). In the case ofmyeloid cells, den-
dritic cells, and B lymphocytes, PU.1 directly participates
in the regulation of genes used formature functions. How-
ever, it has other roles as well, since it is essential for the
generation and survival of progenitors for multiple line-
ages, including those likeTcells,where its role is restricted
to early phases (Scott et al. 1994; Spain et al. 1999; Dakic
et al. 2005). In fact, T-lineage cellsmust silence PU.1 com-
pletely before they aremature (Anderson et al. 2002). PU.1
binds to tens of thousands of genomic sites, which differ in
erythroidcells,myeloidcells,Bcells, andearlyTcells (Ghi-
sletti et al. 2010; Heinz et al. 2010; Wontakal et al. 2011,
2012;Ridinger-Saisonet al. 2012;Zhanget al. 2012;Ostuni
et al. 2013), but in all of these cases, the majority of the
binding sites detected are likely to be nonfunctional. To
clarify why this regulatory protein is so important for
hematopoiesis, we dissected its role in a developmental
pathway where its function is restricted to the earliest un-
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Multipotent precursors from the bone marrow home to
the specialized microenvironment of the thymus, which
induces their entry into the T-lineage developmental pro-
gram. The earliest T-cell precursors in the thymus, called
early thymic progenitors (ETPs) orKit+DN1 (DN is double
negative, CD4− CD8−; Kit+ DN1 is Kit++ CD44+ CD25−),
still harbor the potential to develop into at least five differ-
ent blood lineages. These cells begin acquiring T-cell
markers in the next stage, DN2a (Kit++ CD44+ CD25+),
but commitment to the T lineage occurs only at the fol-
lowing stage, DN2b (Kit+ CD44+ CD25+) (Yui et al. 2010).
T-cell receptor (TCR) expression begins in the following
stage, DN3 (Kit− CD44− CD25+). Notch signals triggered
by the Delta-like 4 (DL4) ligand expressed on thymic stro-
mal cells drive this processbypromoting theT-lineage fate
andblocking access to alternate lineages (Ikawaet al. 2006;
Rothenberg 2007; Hozumi et al. 2008). Development
through these early DN stages is accompanied by the
precisely coordinated expression of transcription factor-
coding genes, includingLyl1,Scl (orTal1), andSpi1 (encod-
ing PU.1), in the early stages until commitment. Mean-
while Tcf7 (encoding TCF-1), Gata3, Tcf12 (encoding
HEB),Runx1, Bcl11b, andGfi1 are up-regulated, with sus-
tained expression of Ikaros,Myb, and Tcfe2a (or Tcf3, en-
coding E2A), among others, which are indispensible for T-
cell development (for review, see Yui and Rothenberg
2014).
Like the other factors expressed only in early stages, ex-
pression of PU.1 is inherited by early T cells from their
prethymic precursors (Rothenberg et al. 2010). PU.1 ex-
pression in the thymus is highest in DN1 and DN2a cells,
decreases with commitment at the DN2b stage, and is fi-
nally shut off in the DN3 stage (Anderson et al. 1999; Yui
et al. 2010). The silencing of PU.1 expression is an impor-
tant event, since continued PU.1 expression can block
T-cell development at a DN2-like stage or divert early
T cells to the myeloid lineage if Notch signaling from
the environment is interrupted (Anderson et al. 2002; Le-
febvre et al. 2005; Franco et al. 2006; Laiosa et al. 2006).
Even inefficient silencing of PU.1 can cause T-cell leuke-
mia (Rosenbauer et al. 2006). PU.1may thus contribute to
the initial developmental plasticity of the cells, especially
their access to PU.1-dependent myeloid cell, B-cell, and
dendritic cell fates. PU.1 expression in multipotent pre-
cursors is indispensable for the development of T-lineage
cells, as T cells fail to develop in a germline PU.1 knock-
out model and PU.1 expression in adult HSCs is also re-
quired for their T-lineage potential (Scott et al. 1994;
Dakic et al. 2005). However, the question has remained
for PU.1 as to how it contributes to the development or
maintenance of early intrathymic T-cell precursors in
which it is expressed.
Understanding the function of PU.1 is challenging
because it is critical for viability in prethymic lymphoid
precursors. Loss of PU.1 function subjects lymphoid pre-
cursors to loss of competitiveness, whereas gain of func-
tion to levels like those in myeloid cells disrupts the
T-cell program as well. To dissect stage-specific functions
of PU.1 in the dynamic context of early T-cell develop-
ment, we needed new approaches for synchronized, effi-
cient removal of endogenous PU.1 activity. We therefore
combined developmentally staged deletion of a condition-
al knockout allele with introduction of dominant-nega-
tive or hypomorphic competitor PU.1 constructs to
perturb specific aspects of PU.1 activity. Our results
show that PU.1 is important for early T-cell proliferation
and may even help to restrict the developmental options
available to these cells. Genome-wide analysis reveals
multiple signaling and cell-biological functions of early
pro-T cells that are directly regulated by PU.1. Important-
ly, we also found that PU.1 regulates the developmental
timing of expression of several key T-lineage genes
through an indirect network linkage revealed by the ef-
fects of an obligate repressor form of PU.1. PU.1 thus ulti-
mately regulates the threshold for progression during
early T-cell development.
Results
PU.1 is required for DN progression and survival
of lymphoid precursors in T-cell differentiation
culture
To investigate whether PU.1 contributes to T-cell devel-
opment during the early intrathymic stages or is only
important in prethymic precursors, we first used a condi-
tional deletion strategy.We deleted PU.1 at specific stages
in early T-cell precursors and tracked the effects on subse-
quent development in OP9-DL1 coculture, an in vitro
system that mimics the thymic environment. First, retro-
virally transduced Cre was used to delete Spi1 from c-Kit+
CD27+ Lin− multilineage hematopoietic precursors from
embryonic day 14.5 (E14.5) fetal livers (fetal liver precur-
sors [FLPs]). Cre+ cells from Spi1-targeted and control B6
mice were then sorted and tracked through culture by
their coexpression of the retroviral NGFR marker. Dele-
tion of Spi1 did not immediately reduce cell yield in
PU.1-deleted cells as compared with Cre-treated wild-
type controls. However, the PU.1-deleted FLPs were inef-
ficient in their ability to differentiate into T-lineage
cells, as seen by the delayed generation and reduced accu-
mulation of CD25+ DN2 cells at days 4–8 (Fig. 1A,B). Over
8–10 d of T-cell differentiation culture, cells with deleted
Spi1 generated considerably fewer progeny (Fig. 1B).
The reduced development of CD25+ DN2 cells from
PU.1-deficient precursors could not be reversed simply
by cotransducing Bcl-xL in a GFP+ retrovirus along with
Cre to inhibit apoptosis (Fig. 1C; Supplemental Fig.
S1A). Sustained expression of Cre itself was toxic to
both wild-type and Spi1fl/fl cells (Supplemental Fig. S1B),
but even at equal survival rates, the differentiation of
the Spi1fl/fl Cre+ cells to CD25+ DN2 stage was specifi-
cally impaired in comparison with B6 Cre+ cells (Fig. 1C;
Supplemental Fig. S1A, arrows). Bcl-xL improved the re-
covery of DN1 cells with complete Spi1 deletion, but,
with or without Bcl-xL, production of CD25+ (DN2–
DN3) cells was impaired in the absence of PU.1 (Fig. 1C;
arrows in Supplemental Fig. S1A). Thus, PU.1 has an im-
portant role in the early T-cell developmental compe-
tence of Kit+ CD27+ FL precursors.
PU.1 regulation of T-cell precursor development
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To test whether PU.1 still affected differentiation or
proliferation once T-cell development was actually under
way, we initiated T-cell development from wild-type and
Spi1fl/fl precursors in OP9-DL1 coculture first, generating
a pool of cells ranging from the ETP/DN1 to the DN2b
stages, then transduced the cells with Cre and Bcl-xL for
48 h, and sorted the transduced DN1 cells for analysis
and reculture. Once sorted, these cells could be tracked
even if they later silenced retroviral expression (Anderson
et al. 2002) to escape Cre toxicity. Although both wild-
type and PU.1 knockout cells proliferated, PU.1 was in-
deed required for optimal proliferation. We stained the
sorted DN1 cells with the cell cycle tracker CellTrace vi-
olet (CTV), returned them to culture, and then analyzed
CTV dilution in their DN1 and DN2 progeny after two
to threemore days (Fig. 2A–E). Normally, proliferation ac-
celerates between the ETP/DN1 and DN2 stages (Fig. 2B;
Manesso et al. 2013), but this acceleration did not occur in
PU.1-deficient cells. Instead, PU.1 knockout DN2 cells
proliferated significantly less than their wild-type coun-
terparts on both day 2 and day 3 of culture (Fig. 2D,E).
Thus, PU.1 is needed for optimal proliferation at the
DN2 stage.
Over 3–5 d, the loss of PU.1 also had a striking effect on
differentiation. Despite less overall proliferation, cells
that had deleted PU.1 at the ETP or DN2a stages consis-
tently differentiated faster than controls, as evaluated by
the cell surface expression of classic DN subset markers
CD44 and CD25 (Fig. 2F,G). When Cre was introduced
in either the ETP or DN2a starting population, PU.1-de-
leted cells progressed more completely from the CD44+
CD25+ DN2 stage to the CD44− CD25+ DN3 stage than
their B6 counterparts by the time of harvest. In contrast,
there was no difference from the controls in the develop-
mental profiles of cells that lost PU.1 at the DN2b stage,
when endogenous PU.1 expression is already down-re-
gulated and the cells have already committed to the T lin-
eage. Thus, in early T cells, PU.1 normally supports
population expansion while restraining differentiation.
PU.1 temporally restricts activation of the T-lineage
developmental program
Toevaluate theeffect of PU.1 lossonT-lineageprogression
as a whole, we examined awell-characterized spectrum of
genes under known developmental control (Zhang et al.
2012; Mingueneau et al. 2013; Yui and Rothenberg 2014).
We transduced Cre and Bcl-xL into Spi1fl/fl or B6 control
FL-derived DN (FLDN) cells after 3 d of differentiation as
in Figure 2A, returned them to OP9-DL1 culture for two
more days, and finally collected the Cre+, Bcl-xL+ cells
sorted intoDN1,DN2a, andDN2b fractions forRNAanal-
ysis (Fig. 3A; Supplemental Fig. S2A). Cre caused efficient
stage-specific deletion of Spi1, as shown by the decrease in
Spi1 (PU.1) RNA in subset populations that were still
phenotypically matched to the controls (Supplemental
A B
C
Figure 1. Deletion of PU.1 in c-Kit+ CD27+ FLPs results in impaired DN progression and poor survival and recovery of early DN stage T
cells. (A) E14.5 B6 and Spi1fl/fl FLPswere infectedwithCre-expressing retroviral supernatant. One day after the infection, Cre+ Kit+ CD27+
cells were sorted and used to start OP9-DL1 cultures. These cultures were harvested on the indicated days and analyzed for DN progres-
sion as shown in the figure. FACS plots are representative of two independent experiments. (B) Plot summarizing Cre+ Spi1fl/fl cell counts
expressed relative to the number of Cre+ B6 cells on day 4 of OP9-DL1 culture, from two independent experiments. Error bars indicate one
standard deviation. (C ) Failure of Bcl-xL to rescue progression to CD25+ (DN2/DN3) stages when PU.1 is deleted. Cells were prepared as in
A, except that theywere doubly transducedwithCre (NGFR+) and Bcl-xL (GFP+) retroviruses or controls. Results are fromone experiment,
representative of two independent experiments.
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Figure 2. PU.1 retards DN progression and enhances proliferation of early T cells. (A) Scheme for cell cycle progression analysis of prog-
eny of PU.1-deleted DN1 cells. B6 and Spi1fl/fl FLPs were cultured on OP9-DL1 cells for 3 d and infected with Cre-expressing and Bcl-xL-
expressing retroviruses. Two days later, Cre+ Bcl-xL+DN1cellswere sorted, loadedwithCTVdye, and put back in freshOP9-DL1 cultures.
Two days and 3 d later, population phenotypes and CTV fluorescence were determined by FACS analysis. (B) Phenotypes of recultured
cells at day 3. (C ) Extents of CTV dilution for progeny of labeledDN1 cells, comparing PU.1-deletedDN1 andDN2 progenywith controls.
Arrows indicate the day 0 CTV mean fluorescence intensity (MFI) for each population shown in the histogram. (D) All four populations
from the histograms in C, superimposed to show the differences in proliferation of various subsets. (E) Relative proliferation of B6 and
Spi1fl/flDN cell populationsmeasured by the differences in dilution of CTV at day 2 and day 3. CTVMFI for each population was normal-
ized to the initial loading value and then plotted relative to the day 2 control B6 DN1 value. (F ) Flowchart showing the design of DN stage
progression experiments. E14.5 B6 and Spi1fl/fl FLPs were cultured on OP9-DL1 for 3 d and infected with a Cre-expressing retrovirus. Cre+
DN1, DN2a, and DN2b populations were sorted and used to seed the cultures analyzed 5 d later inG andH. (G) DN stage progression of
cells descended from the indicated starting populations, based onCD44 andCD25 expression. The diagram at the right shows populations
defined by the four quadrants. (H) Population distributions of progeny subsets descended from the indicated Cre+ starting populations,
averaged from two independent DN progression experiments as in F and G. Error bars represent one standard deviation.
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Fig. S2B).AsPU.1protein is very stable (Kuehet al. 2013), it
could take at least 2 d to clear pre-existing PU.1 protein
from the cells, but early changes in gene expression
emerged as PU.1 levels decreased.
Previous work had identified genes that can be up-regu-
lated or down-regulated by forced high-level PU.1 expres-
sion in early T cells (Anderson et al. 2002; Dionne et al.
2005; Franco et al. 2006; Laiosa et al. 2006; Del Real and
Rothenberg 2013), but it was not clear until now whether
normal developmental expression levels of these genes
depend on endogenous levels of PU.1. Although the ef-
fects were weak, acute deletion showed that several genes
expressed specifically in theDN1 and earlyDN2 stages do
depend on full expression of PU.1 in these early T-lineage
cells. Cd11b (Itgam and Mac1), Mef2c, and Bcl11a were
all detectably down-regulated in PU.1 knockout cells
as compared with the corresponding B6 cells (Fig. 3B,C;
Supplemental Fig. S3A,B). In contrast, T-lineage-associat-
ed genes—including two isoforms of Tcf12 (HEBalt and
HEBCan), Ikaros, Runx1, Ets2, and Myb, most of which
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Figure 3. Deletion of Spi1 leads to derepression of T-lineage genes. (A) Flowchart for obtaining B6 and Spi1fl/fl DN1, DN2a, and DN2b
cells to determine the effect of loss of PU.1 on the T-lineage developmental program. cDNAwas prepared from DN subsets sorted in A,
and gene expression changes were measured in the indicated populations using quantitative PCR (qPCR). (B–J) Actin-normalized expres-
sion values averaged from two independent experiments are expressed as the fold change relative to the B6 DN1 values (B,D,F,I ) or the B6
DN2a values (C,E,G,H,J). The resulting datawere plotted for phase 1 and alternate lineage genes (B,C ), T-lineage genes (D,E), components
of the Notch signaling pathway (F–H), and alternate lineage genes (I,J). Error bars represent one standard deviation. Significant differences
at P < 0.05 are indicated with an asterisk (DN1 and DN2) and pound sign (DN2b).
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increase in expression between DN1 and DN2b/DN3—
were significantly up-regulated in PU.1 knockout subsets
as compared with their B6 counterparts, and increased
Tcf7 expression was also seen in some DN1 samples (Fig.
3D,E; Supplemental Fig. S3A,C). Overexpressed PU.1 can
antagonize Notch signaling in early T cells (Del Real and
Rothenberg 2013), and, accordingly, multiple Notch-acti-
vated genes likeNotch3,Deltex1,Hes1,Hes5, andHEBalt
were up-regulated in the absence of PU.1 in all DN subsets
(Fig. 3F–H; Supplemental Fig. S3A,D). This effect was not
just an aspect of developmental acceleration. Notably,
Nrarp, the loneNotch target gene that naturally decreases
in expression fromDN1 toDN2b,was also up-regulated in
the PU.1-deficient DN2a and DN2b cells relative to con-
trols. Thus, endogenous PU.1 normally restrains the ex-
pression of multiple Notch targets, with the strongest
effects at stages when their expression is in transition.
Interestingly, loss of PU.1 also led to the up-regulation
of additional genes that are expressed during the early
T-cell stages but whose best-known function is to support
the development of variant or alternate lineages. These in-
cluded Sox13 (γδ T cells) andGata2 (mast cells or progen-
itor cells), which were significantly up-regulated (Fig. 3I;
Supplemental Fig. S3A,E), and, in some samples, Zbtb16
(PLZF and innate lymphocytes) as well (Supplemental
Fig. S3). PU.1 loss also regularly resulted in higher Kit ex-
pression. Although these effects were weak, they were
likely to be functionally significant. When PU.1-deleted
cells were transferred to permissive conditions for natural
killer (NK) cell development, progeny of PU.1-deficient
FLPs regularly yielded more NK cells than controls (Sup-
plemental Fig. S4). Taken together, these data raise the
possibility that PU.1 not only limits the up-regulation of
T-cell programgenes but alsomay play a role in restricting
the range of alternative lineage potentials of developing
thymocytes during the stages when it is expressed.
PU.1-Engrailed (PU.1-Eng) fusion construct as a tool
to investigate the role of Spi1 in early T cells
Conclusions fromtheknockout data alonewereweakened
by the modest size of the effects that we could measure in
this dynamic developmental context. Although Cre re-
combinase could excise Spi1DNAwithin 24 h after infec-
tion, the effects were weak until pre-existing PU.1 protein
was cleared from the cells. Protein was clearly reduced by
48 h (data not shown), but the increased time could also in-
crease the indirect effects fromaltered developmental pro-
gression. We therefore sought alternative strategies to
neutralize PU.1 activity quickly and synchronously at a
particular stage and time point. To competitively inhibit
endogenous PU.1 protein,wedesignedmodified PU.1 con-
structs that would incorporate the full PU.1-ETS DNA-
binding domain but delete its transactivation and other
protein interaction domains (Fig. 4A).
To enhance detection of competitive inhibitor effects,
we created a dominant interfering form of PU.1 with
known repressive activity. A PU.1-Eng fusion was con-
structed (Fig. 4A) in which the repression domain of the
Drosophila Engrailed protein is fused to the DNA-binding
ETS domain of PU.1, maintaining the DNA-binding spe-
cificity of PU.1. By recruitment of Groucho/TLE family
corepressors to the Engrailed domain, this should consis-
tently repress PU.1 target genes, antagonizing wild-type
PU.1 function where wild-type PU.1 activates and paral-
leling wild-type PU.1 function where it represses (Han
and Manley 1993; Jimenez et al. 1997; Tolkunova et al.
1998). Besides PU.1-Eng, we created PU.1-ETS, a con-
struct expressing only the DNA-binding ETS domain of
the PU.1-Eng fusion construct, to serve as a control for
the passive target site-binding activity of PU.1-Eng. An ad-
ditional construct, PU.1-ΔDEQ, deleted only the acidic
and glutamine-rich transactivation domains.
Specificity of PU.1-Eng: antagonism of
PU.1-dependent gene activation without
effects on other ETS family targets
The target specificity and ability of these constructs to
block wild-type PU.1 function were verified using lineage
diversion of the DN3-like Adh.2C2 thymoma cell line by
wild-type PU.1 (Dionne et al. 2005; Del Real and Rothen-
berg 2013). These cells do not express any PU.1, but ectop-
ic expression of wild-type PU.1 in Adh.2C2 cells causes
dose-dependent myeloid diversion marked by down-regu-
lation of T-cell surfacemarker CD25 (Il2rα) and up-regula-
tion of the myeloid marker CD11b (Itgam) (Fig. 4B). In
contrast to wild-type PU.1 (Fig. 4B, WT), PU.1-Eng and
PU.1-ETS could not transform the Adh.2C2 cells to
CD25−/low CD11b+ cells (Fig. 4B, top) despite high-level
expression and lack of toxicity. However, when coex-
pressed with wild-type PU.1, both PU.1-ETS and PU.1-
Eng dominantly inhibited PU.1-drivenmyeloid diversion,
verifying that they could competitively neutralize normal
PU.1 (Fig. 4B, bottom row). While PU.1-ΔDEQwas able to
reduce myeloid diversion, it was the weakest inhibitor of
wild-type PU.1 in the group.
In primary multilineage precursor cells, Kit+ CD27+
Lin− FLPs, PU.1-Eng could also block expression of known
positive regulatory targets of PU.1; i.e., growth factor re-
ceptor genes Flt3 and Il7r (DeKoter et al. 2002; Carotta
et al. 2010). Transduction of PU.1-Eng caused sharp
down-regulation of both surface Flt3 and IL-7 receptors
within a day. The effect was gene-specific, since the Kit+
CD27+ cells were still present (Fig. 4C) at day 1. However,
loss of these growth factor receptors was followed by
severe loss of the precursors 1 d later, and subsequent lym-
phoid developmentwas profoundly inhibited. Thus, PU.1-
Eng acts faster but has effects on this population similar to
those of PU.1 deletion (cf. Fig. 1; Carotta et al. 2010).
Transduction of PU.1-Eng into primary DN1 and
DN2a/DN2b pro-T cells had dramatic effects on gene ex-
pression, as described in detail below. Here, PU.1-Eng
down-regulated both Itgam and another gene, Coro2a,
by more than fourfold within 24 h (Fig. 4D). These effects
were abolished by the single amino acid mutation
W215G, which disrupts DNA-binding activity (Fig. 4D).
To assess whether these effects truly reflect competi-
tion with endogenous PU.1, we also measured PU.1-Eng
“side effects” by testing whether it also affects gene
PU.1 regulation of T-cell precursor development
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expression in a later pro-T-cell context where endogenous
PU.1 is already silent. For this we used the parental
Adh.2C2 pro-T-cell line, which does not express any
PU.1 naturally but can express other ETS family target
genes through the action of other ETS factors; e.g., Ets1,
Ets2, and Fli1. When we introduced PU.1-Eng into
Adh.2C2 cells alone, we found that T-cell genes in general
and even those previously linked to Ets1-binding peaks in
human cells (Hollenhorst et al. 2009) were unchanged in
expression (Fig. 4E) despite strong accumulation of PU.1-
Eng protein (data not shown). The lack of PU.1-Eng effect
contrasted with that of wild-type PU.1, which caused re-
pression of many of these genes in Adh.2C2 cells, includ-
ing Ets1 itself (Fig. 4E; Dionne et al. 2005; Del Real and
Rothenberg 2013). Thus, the PU.1-Eng construct is selec-
tive and does not compete with ETS factors generally.
Negative regulation of T-cell development by PU.1 is
indirect: PU.1-Eng causes derepression of the T-lineage
developmental program
The fact that PU.1 deletion accelerates T-lineage develop-
mental progression implies that the ability of overex-
pressed PU.1 to repress multiple T-lineage genes (Fig.
4E; Dionne et al. 2005; Franco et al. 2006; Del Real and
Rothenberg 2013) is physiologically significant. On one
A B
C D E
Figure 4. PU.1 constructs retain target gene specificity and are able to blockwild-type (WT) PU.1 function efficiently. (A) Cartoon show-
ing the domain organization of wild-type PU.1 and the various PU.1 constructs used in this study. (B) PU.1-Eng, PU.1-ETS, and PU.1-
ΔDEQ can block wild-type PU.1 activity. Adh-2C2 cells were infected with various constructs, as indicated at the top of each panel. After
48 h, diversion to the myeloid lineage was determined by analyzing the surface up-regulation of CD11b. The data in the FACS plots are
representative of two independent experiments. (C ) Repression of Il7r and Flt3 in progenitors by PU.1-Eng. E14.5 B6 FLPswere transduced
with PU.1-Eng and cultured without OP9 stromal cells in medium supplemented with 1 ng/mL SCF and 5 ng/mL each Flt3L and IL-7.
Cultures were harvested after 48 h and analyzed by flow cytometry for the indicated markers (representative of two independent exper-
iments). (D) Repression of Itgam andCoro2a depends on the integrity of the PU.1-Eng DNA-binding domain. Plots show gene expression
measured by qPCR in sorted FLDN cells 24 h after transduction with empty vector (EV; blue), PU.1 wild type (red), PU.1-Eng (gold), or
PU.1-Eng W215G (green). The effects of PU.1-Eng were compared with PU.1 wild type in DN2a and DN2b cells (two experiments),
and PU.1-Eng was compared with PU.1-Eng W215G in DN1 and total DN2 cells (two separate experiments). Values (average ± range)
are shown relative to Actb on a log10 scale. (E) The lack of effect of PU.1-Eng in Adh.2C2 pro-T cells. Adh.2C2 cells were transduced
with the constructs indicated and harvested at 48 h for gene expression analysis by qPCR. Average, Actin-normalized log10 expression
values from two independent experiments were used to generate the heat map shown in the figure. All values are row-normalized, and
the color scale at the right denotes 30-fold up-regulation (dark red) and 30-fold down-regulation (dark blue) of gene expression.
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hand, PU.1 could repress each of these genes individually
through their cis-regulatory elements, either through
dedicated repressive sites or by interfering with access
by positively regulating ETS factors. Alternatively, it
could positively regulate the expression of some interme-
diate repressors that in turn repress theT-lineage program.
As shown in Figure 5A, if PU.1 directly repressed T-line-
age genes, PU.1-Eng fusion protein should have the
same effect owing to its obligate repressor activity. In con-
trast, if PU.1 inhibited them indirectly by positively
regulating expression of a repressor, then these T-lineage
identity genes would be among those up-regulated by
PU.1-Eng.
In primary DN2a and DN2b cells, PU.1-Eng had a pro-
nounced effect on T-lineage-specific genes. As previously
reported, multiple T-lineage genes were down-regulated
in primary pro-T cells overexpressing wild-type PU.1 pro-
tein, whereas the obligate repressor PU.1-Eng construct
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Figure 5. PU.1-Eng transduction up-regulates T-lineage-specific gene expression. (A) Cartoon showing alternativemechanisms bywhich
wild-type PU.1 could repress T-cell genes and the use of PU.1-Eng to distinguish between these possibilities. (Left panel) PU.1 could
directly repress T-lineage genes by recruiting repressors to silence each gene individually or up-regulate the expression of a repressor
“X” that could in turn repress the T-cell program. The effects of obligate repressor PU.1-Eng under the two scenarios are shown in the
right panel. (B) Schematic of experiments to generate the data shown in C and D and Supplemental Figure S6, A–F. Bcl2-tg FLDN cells
were used to enhance viability under perturbation. They were processed as shown and sorted to purify DN1, DN2a, and DN2b cells
for gene expression analysis by qPCR. (C,D) The retroviral supernatants used to express various constructs are indicated above each
lane. Sorted DN stage cells from two to three independent experiments were pooled to obtain each set of qPCR data. Average, Actin-nor-
malized log10 expression values from two such pooled data sets were used to generate the heat maps shown in the figure. All values were
row-normalized to the controlDN2a (C ) or control DN1 (D) sample, and the common color scale at the right denotes 30-fold up-regulation
(dark red) and 30-fold down-regulation (dark blue) of gene expression. Boldface gene names indicate Notch-activated genes.
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had the reverse effect, up-regulating T-lineage genes
relative to empty vector (EV) controls (Fig. 5C,D; cf. Fig.
4E; Supplemental Figs. S5B, S6A–F [representative bar
graphs]). Significantly, this set included almost all of the
T-cell genes that were up-regulated in the PU.1 knockout
cells described above (Fig. 3B–E), but the magnitudes of
the effects here were much greater. Thus HEBAlt, HEB-
Can,Tcf7,Gata3, Ets1, Ets2, Lef1,Rag1,Cd3e, Ptcra,Del-
tex1, Gfi1, and Ikaros were all up-regulated by PU.1-Eng
and down-regulated by PU.1 wild type. Strikingly, stage-
specific T-lineage genes were also turned on precociously
in PU.1-Eng-expressing cells. PU.1-Eng transduced ETP/
DN1 cells turned on expression of genes that have strictly
DN2- and DN3-specific timing of activation in normal
cells (Fig. 5D; Supplemental Fig. S6A). These included im-
portant T-lineage regulators like Ets1, Bcl11b, and Lef1 as
well as the recombinase gene Rag1 and the TCR complex
gene Cd3e (Yui et al. 2010; Zhang et al. 2012). These re-
sults support the smaller effects in the same direction
seen upon conditional deletion of the Spi1 gene (cf. Fig.
3), indicating that PU.1 normally limits the timing as
well as magnitude of activation of T-cell genes.
These effects depended on the repression domain of
PU.1-Eng rather than a simple competition for DNA oc-
cupancy because PU.1-ETS and also PU.1-ΔDEQ were
virtually ineffective at activating anyT-cell genes (Supple-
mental Fig. S5B). The effects were also not an artifact of
forced Engrailed domain expression because expression
of PU.1-Eng with a mutated DNA-binding domain (PU.1-
Eng W215G) did not up-regulate these genes (Supplemen-
tal Fig. S5C). Thus, the up-regulation of T-cell genes by
PU.1-Eng implies that endogenous PU.1 normally repress-
es these genes indirectly to cause T-cell differentiation
delay.
Activation of Notch target genes and alternative lineage
genes by obligate repressor PU.1
PU.1 could indirectly repress these genes in normal cells
by positively regulating the expression of a T-lineage-
specific repressor or a Notch signaling antagonist. Indeed,
complementing previous results with PU.1 gain of func-
tion (Del Real andRothenberg 2013), expression ofNotch1
itself was only slightly increased in PU.1-Eng-expressing
cells, but many direct targets of Notch signaling—includ-
ingHes1,Deltex1,HEBalt, andNrarp—were up-regulated
(Fig. 5C,D, boldface gene names; Supplemental Fig. S5B).
Since the cellswere assayed just a dayafter PU.1-Eng trans-
duction, these changes could reflect a rapid enhancement
of signaling by existing Notch1 rather than longer-term
pathway reinforcement due to network-level positive
feedback. Thus, at least part of the activation of the
T-cell program could reflect removal of a constraint on
Notch signaling.
In addition to the effects on T-lineage genes, we also
found that several alternate lineage genes were also
down-regulated by wild-type PU.1 but up-regulated in re-
sponse to PU.1-Eng expression in the DN1/ETP stage (Fig.
5D). These included NK or innate lymphoid cell (Zbtb16
and Il2rb) and mast cell (Cpa3 and Gata2) lineage-associ-
ated genes aswell as the broadly used progenitor cell genes
like Kit and Zfpm1. These stronger effects confirmed the
results seen when many of these genes were also up-regu-
lated in the PU.1 knockout FLDN cells described above
(Fig. 3E). Thus, PU.1 may help to constrain access to in-
nate lymphoid lineage fates even while it preserves access
to myeloid and dendritic fates during the early phase of
T-cell development.
Genome-wide analysis of genes regulated
by PU.1-Eng
The interpretation of these PU.1-Eng effects relies on the
assumption that this construct selectively represses phys-
iological PU.1 target genes. To evaluate this critically, we
carried out genome-wide analysis of the early impacts of
PU.1-Eng and PU.1-ETS expression on the DN2a pro-T-
cell transcriptome, comparing these with global patterns
of endogenous PU.1 binding and global developmental
regulation. To identify genes that undergo rapid changes
in expression in response to PU.1-Eng, primary FLDN2a
cells were sorted ∼20 h after transduction with EV,
PU.1-Eng, or PU.1-ETS and were analyzed using RNA se-
quencing (RNA-seq). Such DN2a cells are unambiguously
engaged in the T-cell pathway yet are still high in natural
PU.1 expression (Yui et al. 2010; Scripture-Adams et al.
2014). Cells from Bcl2 transgenic (Bcl2-tg) mice were
used as in Figure 5 to improve recovery of cells after regu-
latory perturbation (Franco et al. 2006; Taghon et al.
2007). The early time point minimized indirect effects
and ensured that the cell surface phenotype was not
yet altered (Supplemental Fig. S7). At this time point,
PU.1-Eng had little if any impact on the major cell cycle
regulators expressed (Supplemental Fig. S6G).
The six samples from two independent experiments
were all still highly concordantwith each other in gene ex-
pression levels at harvest (Pearson’s r 0.84–0.91 for all
pairwise comparisons), with EV and PU.1-ETS transduced
samples being closest. DESeq comparisons showed few
genes significantly affected in the PU.1-ETS transduced
samples (Supplemental Table S1). However, in the PU.1-
Eng transduced cells, there were selective, reproducible
gene expression changes despite the short duration of the
perturbation. Of the genes meeting the threshold stat-
istical criteria (log2 fold change > |1|, false discovery rate
[FDR] < 0.1 in at least one and FDR < 0.2 in both sets),
110 genes were reproducibly down-regulated, and 78
genes were up-regulated (Fig. 6A). Both down-regulated
and up-regulated genes were comparable in their fold
changes in expression, their reproducibility of response,
and the geometricmean adjusted P-values for these effects
in the two experiments (Fig. 6A; Supplemental Table S1).
Examples of each group are shown in Figure 6, B–G, in
which RNA-seq tracks for DN2 samples transduced
with EV, PU.1-Eng, and PU.1-ETS in the two experiments
(red and green boxes) are compared with RNA-seq tracks
showing normal developmental expression change (blue
boxes), with corresponding histone H3K4me2-marking
tracks, and with PU.1-binding tracks from unperturbed
DN1, DN2a, DN2b, and DP cell samples (Zhang et al.
Champhekar et al.
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2012). These results show that most of these regulated
genes are associated with PU.1 occupancy sites in normal
cells, often correlated with distinct H3K4me2 peaks, and
that these genes may have highly pronounced changes in
expression with development.
Selective regulation of genes by PU.1-Eng: correlation
with endogenous PU.1 binding
If PU.1-Eng is really an obligate repressor and all up-regu-
lation is indirect, then the repressed genes should bemore
enriched for direct targets of endogenous PU.1 than the
up-regulated genes. We showed previously that endoge-
nous PU.1-binding sites in DN1, DN2a, and DN2b pro-
T cells are associated with many active promoters and
enhancers genome-wide (Zhang et al. 2012). Among the
genes rapidly affected by PU.1-Eng, many had multiple
binding sites for endogenous PU.1 (Supplemental Table
S2). These PU.1 peakswere not always found at promoters
of the PU.1-Eng-affected genes: Many affected genes had
only intronic or flanking intergenic PU.1 sites. Converse-
ly, genes with PU.1 only at the promoters were often
unaffected by PU.1-Eng entirely (e.g., Uggt1 and Arid5a,
the genes flanking Neurl3 in Fig. 6D).
Zap70
E2f2
Zfpm1
Nfam1
Ffar2
Neurl3
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E F G
Figure 6. Identification of positive and negative PU.1 target genes by genome-wide analysis. (A) Effects on expression of top-scoring PU.1-
Eng-repressed and PU.1-Eng-activated genes in two independent RNA-seq experiments. Data from the two experiments are shown as fold
change (log2 scale) from EV samples in the same experiment. Genes profiled in B–G are identified. (B–G) University of California at Santa
Cruz (UCSC) genome browser portraits of three genes down-regulated by PU.1-Eng (B–D) and three genes up-regulated by PU.1-Eng (E–G).
Boxed tracks showRNA-seq data from two different experiments (magenta and green) comparing EV, PU.1-Eng, and PU.1-ETS transduced
cellswith normal reference samples (blue) fromDN1,DN2a,DN2b, andDP stages. Red tracks showpositions ofH3K4me2 histonemarks,
and brown tracks showbinding of PU.1 based on chromatin immunoprecipitation (ChIP) combinedwith deep sequencing (ChIP-seq) in the
same reference cell types. Direction of transcription is right to left inB–D and left to right inE–G. Full scales for vertical axes inB–G are 2.5
reads per million (RPM) for all H3K4me2 ChIP-seq, 5 RPM for all PU.1 ChIP-seq, 1.5 RPM for all RNA-seq tracks in B–D, 5 RPM for all
RNA-seq in E and F, and 3 RPM for all RNA-seq in G.
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Figure 7. Characteristics of PU.1 target genes identified by genome-wide analysis. (A) Histogram comparing in vivo PU.1-binding distri-
butions among genes repressed by PU.1-Eng (red), genes up-regulated by PU.1-Eng (light green), and control genes expressed stably and
unaffected by PU.1-Eng (dark blue). The X-axis indicates histogram bins and summed ChIP-seq signals for each gene (at top four sites),
and the Y-axis shows the fraction of genes in the set in the indicated bin. (B) Developmental indexing of the two independent PU.1-
Eng (ENG), PU.1-ETS (ETS), and EV transduced samples as compared with normal reference cells (Zhang et al. 2012). Principal compo-
nents were based on expression patterns of 173 regulatory genes, as described in the Supplemental Material (Supplemental Table S3).
(C,D) Gene set enrichment analyses of the effects of PU.1-Eng on genome-wide transcription relative to normal developmental patterns
of expression. The panels shown compare the enrichments of a set of developmentally down-regulated genes (cl. 3, 7, 9, and 23) and a set of
developmentally up-regulated genes (cl. 1 and 6) against the full set of expressed loci (Supplemental Table S4J), ranked by fold change
caused by PU.1-Eng. (NES) Normalized enrichment score; (positive NES) enriched; (negative NES) depleted. For full results, see Supple-
mental Table S4. (E–H) Effects of wild-type PU.1 addition or endogenous PU.1 deletion on PU.1-Eng-repressed target genes Gpx1, Lyn,
Sh2b2, Neurl3, and Ptpn6 in FLDN1 cells (E,F ) and FLDN2a and FLDN2b cells (G,H). Samples were prepared as described for PU.1
wild-type and PU.1-Eng transduced cells in Figure 5 (E,G) and for Cre+ control and Spi1fl/fl cells in Figure 3 (F,H). Gene expression levels
determined by qPCR are shown on a log10 scale relative to Actb in E and G and on a linear scale relative to control levels in B6 DN1 or
DN2a cells in F and H. Averages and the range of values from two independent experiments are shown.
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Notably, however, the densities and intensities of
PU.1 occupancy in normal DN1 and DN2a cells (Zhang
et al. 2012) were higher around the genes repressed by
PU.1-Eng than around genes activated by PU.1-Eng or
around genes unaffected by PU.1-Eng. For comparison,
we calculated an in vivo PU.1 occupancy index for each
gene by summing the intensities of chromatin immuno-
precipitation (ChIP) combined with deep sequencing
(ChIP-seq) signals in DN1 and DN2a stages at the four
strongest sites associated with that gene (Supplemental
Table S2; see the Supplemental Material; data from Sup-
plemental Table 5 in Zhang et al. 2012). We compared
these occupancy index values for the highest-confidence
lists of up-regulated and down-regulated genes (Fig. 6A)
with each other and with a control set of 841 genes that
are expressed stably throughout early T-cell development
and are unaffected by PU.1-Eng (Fig. 7A, “control gene
set”; Supplemental Table S2; Zhang et al. 2012). Figure
7A shows the distributions of PU.1 occupancy scores in
the three groups as a histogram. PU.1 occupancy scores
were not significantly different between the controls
and the PU.1-Eng-activated genes but trended higher for
the PU.1-Eng-repressed genes (Fig. 7A). Themost strongly
occupied genes were enriched among the genes most
sensitive to PU.1-Eng repression, and these were also
most likely to show weaker but detectable repression
by PU.1-ETS (Supplemental Tables S1, S2). Thus, genes re-
pressed by PU.1-Eng, but not genes activated by PU.1-Eng,
were highly enriched for endogenous PU.1 occupancy at
associated sites, as compared with the average occupancy
for nonregulated genes.
Selective regulation of genes by PU.1-Eng: correlation
with developmental regulation
All of the samples analyzed were still clearly DN2 cells,
as shown by a developmental index based on expression
of 173 regulatory genes (Fig. 7B; Scripture-Adams et al.
2014), which showed all six to cluster closely within the
DN2a/DN2b interval (Supplemental Table S3; see the
Supplemental Material). However, these cells express
both genes that are down-regulated (including Spi1 itself)
and genes that are up-regulatedwith development. To test
whether PU.1-Eng preferentially affects genes that are ex-
pressed while endogenous PU.1 is present, we used gene
set enrichment analysis (GSEA), exploiting our previous
classification of all developmentally regulated genes into
clusters according to expression patterns (Supplemental
Table S4H,I; Zhang et al. 2012). We ranked 11,634 ex-
pressed genes according to their fold changes in response
to PU.1-Eng or PU.1-ETS versus EV (see the Supplemental
Material; Supplemental Table S4J) and then used GSEA to
determine which expression pattern clusters were en-
riched at the top or bottom of the ranked list. PU.1-regu-
lated gene sets previously defined in myeloid precursors
by DeKoter and colleagues (Kamath et al. 2008) were
also tested for enrichment. PU.1-ETS effects were insig-
nificant, but PU.1-Eng had highly significant effects (Fig.
7C,D; Supplemental Table S4B–E). Genes with DN1–
DN2a-biased expression patterns (clusters 3, 7, 9, and
23) were strongly overrepresented among genes repressed
by PU.1-Eng (Fig. 7C, top), while genes that are up-regulat-
ed as endogenous PU.1 is shut off (clusters 1, 6, and 25)
were depleted (Fig. 7C, bottom). Genes previously defined
as PU.1 targets in myeloid cells (Kamath et al. 2008) were
also enriched among PU.1-Eng-repressed genes (Supple-
mental Table S4B,I). In contrast, genes that increase in ex-
pression during T-cell commitment (clusters 1 and 6) and
later (cluster 25) were more represented among genes
up-regulated by PU.1-Eng (Fig. 7E,F; Supplemental Table
S4D), confirming the acceleration effect inferred above
(cf. Fig. 5). Thus, overall, genes repressed by PU.1-Eng,
but not those activated by PU.1-Eng, were expressed at
stages when endogenous PU.1would naturally be present.
In summary, although genes activated by PU.1-Eng in-
clude indirect targets, the PU.1-Eng-repressed genes are
highly enriched for direct, functional targets of PU.1
regulation.
New targets for PU.1 activity in early T cells
The comparison of PU.1-Eng effects with those of forced
expression of wild-type PU.1 and with PU.1 deletion re-
vealed multiple target genes that had not been implicated
previously in early T-cell development. Gene ontology
(GO) analysis of PU.1-Eng-repressed genes (Supplemental
Table S5) showed enrichment of Kyoto Encyclopedia of
Genes and Genomes (KEGG) pathways (P-value < 10−3),
including cell adhesion, leukocyte transendothelial mi-
gration, chemokine signaling, B-cell receptor andTCR sig-
naling, and cytokine–cytokine receptor signaling as well
as developmental pathways such as osteoclast differen-
tiation and hematopoietic cell lineage. Interestingly, sev-
eral genes were associated with negative regulation of
immune responses (P-value < 10−8). These genes should
strongly affect the basic cell biology of environmental
responsiveness and survival of the early pro-T cells, in-
cluding not only signaling but also further aspects of che-
motaxis, cytoskeletal activity, and resistance to oxidative
stress.
Among the top PU.1-Eng-repressed geneswere glutathi-
one peroxidase Gpx1; Src family tyrosine kinase Lyn; E3
ubiquitin ligase Neurl3 (Lincr); signaling adaptor Sh2b2;
NFAT-activatingmoleculeNfam1; actin organization fac-
torCoro2a; and genes encoding two aquaporins and sever-
al regulator of G-protein signaling (Rgs) factors, GTPase-
activating factors like Dock10, the G-protein γ2 subunit
(Gng2), chemokine receptor Ccr2, and G-protein-coupled
receptors, including fatty acid receptor Ffar2 (Gpr43), pro-
ton sensor Gpr65, and Gpr141. Two important protein ty-
rosine phosphatase genes—Ptprc (CD45) and Ptpn6 (SHP1
or “Motheaten”)—were also highly sensitive. Evidence
from independent experiments confirmed PU.1 as a direct
activator ofGpx1, Lyn,Neurl3, Sh2b2, and Ptpn6 in early
T cells (Fig. 7E–H). For these genes, PU.1-Eng had effects
similar to the deletion of endogenous PU.1 (Fig. 7F,H). Ad-
ditionalwild-typePU.1 further up-regulatedmanyof these
genes (Fig. 7E,G), suggesting that the endogenous PU.1
supply is not saturating for these (Figs. 4D, 7E,G). These
target genes present myriad options for PU.1-dependent
PU.1 regulation of T-cell precursor development
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contributions to the cell biology and in vivo behavior of
early T-lineage precursors.
Selective roles for PU.1 in the progenitor-associated
regulatory gene network
A cohort of regulatory genes that we termed “phase 1”
genes have their highest expression in the DN1/ETP
stage, like PU.1, and are then silenced during commit-
ment. PU.1 can positively regulate several of these genes
in gain-of-function experiments (Del Real and Rothenberg
2013). Despite showing responses weaker than those of
the high-confidence targets (Fig. 6A), a broader set of these
regulatory genes was also scored as “enriched” among the
PU.1-Eng-repressed genes in the GSEAs, supporting func-
tional PU.1 input of some kind (Supplemental Table S4,
gene scores). To determine whether these were positive
or negative targets of wild-type PU.1, we compared their
responses to overexpression of PU.1-Eng and wild-type
PU.1 in primary pro-T cells.
As expected, Bcl11a, Lmo2, and Mef2c were up-regu-
lated by added wild-type PU.1, in accord with effects
of PU.1 deletion (Fig. 3) and PU.1-Eng, indicating that
they are positive targets of PU.1 (Supplemental Fig. S8).
However, another group of phase 1 regulatory genes—
including Tal1, Mycn, and Erg—were repressed rather
than activated by addition of wild-type PU.1, even more
strongly than by PU.1-Eng (Supplemental Fig. S8). In-
terestingly, quantitative PCR (qPCR) signals from the ex-
ons not included in the PU.1-Eng or PU.1-ETS constructs
indicated that Spi1 itself is under mild negative autoregu-
lation in early T cells as well (data not shown). Thus, PU.1
works as a complex positive and negative modulator of
multiple regulatory loci in early T-cell development and
not simply by promoting a generally immature state.
Discussion
PU.1 plays an essential role for the development of mye-
loid and B-lineage cells (for whichmultiple lineage-specif-
ic PU.1 target genes have been identified), differentiation
to the earliest myeloid and lymphoid precursors (Back
et al. 2005; Iwasaki et al. 2005; Nutt et al. 2005), and
HSC maintenance (Staber et al. 2013). While it has been
clear that T-cell development is also severely affected in
the absence of PU.1, these results came from experiments
in which PU.1 was deleted at prethymic stages. Only lim-
ited roles of PU.1 have been revealed by deletion of PU.1
in T cells after the DN stages, when it is normally best
expressed (Chang et al. 2010; Jabeen et al. 2011). Con-
versely, PU.1 overexpression can block T-cell develop-
ment and repress the T-lineage program, sometimes
diverting these cells to the myeloid lineage (Anderson
et al. 2002; Lefebvre et al. 2005; Franco et al. 2006; Laiosa
et al. 2006; Del Real and Rothenberg 2013), implying that
its endogenous expression is mainly a regulatory hazard.
Here, however, focusing on the earliest stages of T-cell de-
velopment, we show that endogenous PU.1 in fact plays
an important role in supporting the proliferation and dis-
tinctive cell-biological features of the earliest cells within
the T-cell pathway itself and regulates the timing of ac-
cess to T-lineage genes throughout the stages when it is
expressed.
In this study, we used an acutely expressed obligate re-
pressor form of PU.1 to search rapidly for geneswith PU.1-
sensitive expression on a genome-wide scale. This was
necessary for two reasons. First, PU.1 binds to >30,000 ge-
nomic sites in developing T cells during the stageswhen it
is expressed (Zhang et al. 2012), engaging a large fraction
of all active genes throughout the genome of early T cells
so that binding cannot be used to predict specific function.
Second, deletion of the PU.1 gene does not affect PU.1
protein pools quickly enough to give developmentally
synchronized effects in this dynamic context. Although
forced expression of any dominant negative comes with
caveats, many genes repressed by the obligate repressor
met expected criteria for true PU.1 targets in that they
were enriched for local PU.1 binding in occupancy
strength and/or site numbers and were enriched for genes
expressed preferentially during stages when PU.1 itself
was present. Genes activated by PU.1-Eng treatment
were not enriched for these criteria. Notably for future
analysis, the results revealed numerous genes with mod-
erate to strong local binding by endogenous PU.1 but no
effect of the PU.1-Eng construct, even with PU.1 sites at
the promoter or in the middle of the gene body. Converse-
ly, many of the PU.1-Eng-repressed genes had no PU.1
binding normally at their promoters but only sites in
intronic or flanking regions. Thus, the perturbation test
was crucial to distinguish functional from nonfunctional
binding. The results rule out trivial models for PU.1-Eng
repression and suggest instead that the effect depends on
recruitment to a particular subset of PU.1 sites that may
be preferentially associated with function. Thus, distinc-
tive features of these sites in future studies may help to
determine the rules for the functional importance of a
transcription factor-binding event.
The impact of endogenous PU.1 activity is to extend the
proliferative capacity of the cells throughDN2 stagewhile
retarding onset of theT-cell differentiation program.Here,
deletional and dominant-negative experiments confirm
that PU.1 activity at normal as well as at supraphysio-
logical levels restricts expression of many T-cell commit-
ment genes even in the presence of environmental Notch
ligands, which drive the T-cell program forward. In part,
thismaybebecause, despite anenvironment rich inNotch
ligands, the intensity of Notch responses is blunted in the
earlyT cells by PU.1 as long as it is present.However, PU.1
is likely to antagonizeT-cell progressionvia additional tar-
gets as well. Moreover, PU.1 also blocks expression of
genes associated with other variant cell fates, such as
Gata2, Zbtb16, Prf1, and probably Il2rb, which could pro-
mote mast cell, innate lymphocyte, or NK cell pathways
that are much less Notch-dependent. PU.1 is capable of
acting as a direct repressor (Rekhtman et al. 2003; Stopka
et al. 2005; Hu et al. 2011; Wontakal et al. 2012; de la
Rica et al. 2013), and our results suggest that it down-regu-
lates Sox13 and Il7r directly. However, its repressive ef-
fects on most T-cell genes work through an indirect
mechanism. The T-cell differentiation genes in the T-
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lineage precursors are precociously activated by the obli-
gate repressor form of PU.1 rather than repressed, indicat-
ing that the differentiation restraint function of PU.1 in
these cells depends on the activation of intermediate
genes. By implication, any binding sites around T-cell
genes are likely to be siteswhere PU.1-Eng-binding impact
is functionally ineffective or else is overwhelmed by the
impact of positive T-cell activatorswhen constraint is lift-
ed. Importantly, the resultsalso imply thatthepositive reg-
ulators for these genes are already available in DN1/ETP
cells before the targets are normally expressed but are
held in check as long as PU.1 levels are high.
The exact pathways through which this indirect regula-
tion occurs still remain to be defined. Our results show
PU.1-dependent targets enriched for a wide range of genes
encoding effectors of signaling (particularly G-protein-re-
lated) and cell biology, many of which were unexpected in
the early T-cell context. Some PU.1-regulated genes also
reflect a continuum with its myeloid-promoting activity
(Itgam, Itgax, Emr1, and Fcgr2b), reminiscent of the over-
lap of PU.1-regulated genes from myeloid and lymphoid
programs reported before in myeloid cells (Kamath
et al. 2008). Thus, it is important that our genome-wide
analysis was of sorted DN2 cells that had already acquired
positive markers of the T-cell program (rather than total
early PU.1+ cells) to exclude any progenitors that might
be initiating other programs. The genes affected are thus
positive regulatory targets of PU.1 specifically within
the early T-cell program. Although some targets like
Ptpn6may later be controlled by other factors once PU.1
is turned off, it is notable that many other new PU.1 tar-
gets are themselves restricted to the early PU.1+ stages.
These results suggest thatmany of the signaling, morpho-
logical, and migratory behaviors of cells in the still-ob-
scure early stages of T-cell development are actually
PU.1-dependent.
PU.1 is coexpressed with multiple transcription factors
that link early T-cell development with prethymic pro-
genitors. Indeed, we found evidence for a positive role
for PU.1 in maintaining the expression of at least three
of these phase 1 regulatory genes: Bcl11a, Mef2c, and
Lmo2. However, our results rule out a role for PU.1 as a
global positive regulator of the phase 1 regulatory genes.
In fact, at least two groups of these genes were affected
by PU.1 in divergent ways: Whereas PU.1 enhanced
expression of one set, it blunted expression of another, in-
cludingGata2,Mycn,Tal1, Erg, andKit.Thus, the phase 1
regulatory state is complex, and the proliferative expan-
sion and slow differentiation functions that it promotes
could be mediated by distinct modules.
In summary, PU.1 operates in early uncommitted pre-
cursors, but its role is not limited to upper levels of the
regulatory hierarchy in these cells. Direct PU.1 regulatory
roles in early T-lineage cells include modulatory effects
on other progenitor regulatory factors and strong impacts
on genes involved in protection from oxidative stress,
multiple signaling pathways, and cytoskeletal organi-
zation. Although PU.1 is not a “master regulator” of the
precommitment regulatory state, it is thus a potent posi-
tive regulator of key elements of precursor cell biology
as well as a highly selective regulator of specific lymphoid
precursor transcription factors. Such targets can mediate
its proliferation support and differentiation timing roles
in early T-cell precursors.
Materials and methods
Mice
Spi1fl/fl mice were bred at the California Institute of Technology
from stock originally derived at the Walter and Eliza Hall Insti-
tute (Dakic et al. 2005). Mice with the Spi1-targeted allele and a
tamoxifen-inducible CreER allele were bred to B6 mice to sepa-
rate these traits and then interbred to generate Spi1fl/fl homozy-
gotes without CreER (referred to as Spi1fl/fl), which were used
in this study. Bcl2-tg mice with a C57BL/6 genetic background
[B6.Cg-Tg(BCL2)25Wehi/J] were used as previously described
(Anderson et al. 2002). All strains were maintained as per institu-
tional animal care and use committee guidelines.
Cell cultures
FL cells from E14.5 (day of plug, E0.5) from Spi1fl/fl × Spi1fl/fl,
C57BL/6 ×C57BL/6, or C57BL/6-Tg(Bcl2) × C57BL/6 crosses
were used to initiate OP9-DL1 cultures using slight modifica-
tions of methods reported previously (Li et al. 2010; Del Real
and Rothenberg 2013; Scripture-Adams et al. 2014). For details,
see the Supplemental Material. The DN3-like Adh.2C2 cell line
has been described previously (Dionne et al. 2005).
Retroviral constructs
Wild-type PU.1 and the W215G mutant form of PU.1 cloned in
the LZRS-IRES-GFP vector were previously described (Anderson
et al. 2002). PU.1-ΔDEQwasmade by deleting the transcriptional
activation domain (amino acids 33–100) of PU.1 while keeping
the rest of the protein intact. The PU.1-Eng construct expresses
a fusion protein, which contains the DNA-binding ETS domain
of PU.1 (amino acids 159–260) fused to the obligate repressor
domain (amino acids 1–298) of the Drosophila Engrailed protein
(S. Acharya, M. Zarnegar, and E.V. Rothenberg, unpubl.). The
PU.1-ETS construct only expresses the ETS domain of PU.1 (ami-
no acids 159–260) and served as a control for the Engrailed con-
struct. Versions of these constructs were also made using a C-
terminal hemagglutinin antigen tag, and this was the form of
PU.1-Eng W215G used in Figure 4. All the above constructs
were cloned into the LZRS-IRES-GFP retroviral vector for use.
Wild-type PU.1 was also cloned in the MSCV-IRES-NGFR vector
and was used in Figure 4B. Tagged PU.1 wild type, PU.1-Eng, and
PU.1-ETS and untagged wild-type PU.1 all bound to genomic
DNA at PU.1 consensus sites in transduced cells (J. Ungerbäck,
A. Champhekar, and E.V. Rothenberg, in prep.). Bcl-xL-MIG-R1
(Cheng et al. 2001) was obtained from Addgene. Constitutively
active Cre in the LZRS-IRES-NGFR vector was described previ-
ously (Li et al. 2010).
Retroviral supernatants were packaged by transfecting Phoe-
nix-Eco cells with retroviral constructs using Fugene 6 (Roche).
Lymphoid cells were transduced with retrovirus particles ad-
sorbed to RetroNectin-coated plates in 4-h incubations at 37°C.
RNA isolation and qPCR
Sorted FLDN populations were used to extract RNA with the
RNeasy minikit (Qiagen).
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Primers and conditions for qPCR are described in the Sup-
plemental Material and Supplemental Table S6. Each reaction
was run in triplicate, the data were normalized to Actin ex-
pression, and mean values from two to three experiments
were expressed as a heat map (Matlab) or plotted as log10-scale
graphs. For statistical analysis, actin-normalized gene expression
values were log10-transformed, and two-tailed Student’s t-tests
(paired, equal variance) were performed to determine the signifi-
cance of differences between expression values. Significant differ-
ences in expression with a P-value < 0.05 are indicated with an
asterisk. Error bars in all plots represent one standard deviation
(more than two biological replicates) or range (two biological
replicates).
Transcriptome profiling and analysis of sequencing data:
DESeq and HTSeq analyses
Total RNA was processed essentially as described (Zhang
et al. 2012). cDNA libraries were sequenced with the Illumina
HiSeq 2000 sequencer following the manufacturer’s protocols
(http://www.illumina.com) and produced between 11 million
and 14 million mapped 50-base-pair (bp) single-end reads per
sample (Gene Expression Omnibus accession no. GSE65344). Se-
quenced reads were mapped onto mouse genome build NCBI37/
mm9 using TopHat, and read alignments were processed by
HTSeq (Anders et al. 2015) as described in detail in the Supple-
mental Material. Count data were analyzed for differentially ex-
pressed genes using DESeq (version 1.16.0, http://bioconductor.
org/packages/release/bioc/html/DESeq.html) (Anders and Huber
2010). Each replicate experiment was analyzed separately, and
168 genes with an adjusted P-value of ≤0.1 in both experiments
were considered to be differentially expressed; this set was aug-
mented by 36 genes with an adjusted P-value of <0.1 in one set
and 0.1 < Padj < 0.2 in the other. Spi1 (Sfpi1) appears in these
gene lists as an “up-regulated gene” only because of the exoge-
nous PU.1-Eng or PU.1-ETS RNA.
Analysis of RNA-seq data: sample classification
and natural PU.1 binding around repressed
and activated genes
For details of genome-wide RNA expression analyses, see the
Supplemental Material. Developmental indexing was carried
out using a set of 173 developmentally regulated transcription
factor genes to monitor the developmental state of our RNA-
seq samples (Scripture-Adams et al. 2014). Briefly, samples were
classified by principal component analysis of these transcript lev-
els (Supplemental Table S3). Principal component loadings for
the 173 genes from the normal samples were used to transform
the values from the six experimental samples.
To determine whether PU.1-Eng-affected genes were endoge-
nous PU.1 targets, genes that were up-regulated or down-regulat-
ed by PU.1-Eng were compared separately with a control set of
nonregulated but well-expressed genes. The control set consisted
of 841 genes from expression clusters 16 and 18 in Zhang et al.
(2012), which are expressed stably from the DN1 to the DP stage,
after the removal of four genes that were affected by PU.1-Eng.
Briefly, supplemental Table 5 from Zhang et al. (2012) (with up-
dated gene names)was used to identify all endogenous PU.1-bind-
ing peaks in the vicinity of each gene on the three lists in theDN1
and DN2a stages. The PU.1 occupancy index for each gene was
then calculated as the sum of the occupancy levels (PU.1 ChIP-
seq reads per million) from the DN1 and DN2a samples at the
four strongest peaks assigned to that gene. See the Supplemental
Material for details and statistics.
Analysis of RNA-seq data: GSEA and GO and pathway
enrichment analyses
For a full description, see the Supplemental Material. For GSEA,
we used theGSEAPreranked tool in order to fully characterize the
effects of PU.1-Eng on developmentally regulated and lineage-re-
stricted gene sets (http://www.broadinstitute.org/gsea/index.jsp).
Briefly, genes were ranked in descending order of mean log2 ratios
between all pairwise comparisons from both RNA-seq experi-
ments. The ranked lists were then compared with distinct devel-
opmental expression pattern clusters from Zhang et al (2012) and
previously identified PU.1 target lists reported inmyeloid precur-
sors (Kamath et al. 2008). Gene sets with FDR < 0.01 were consid-
ered to be significantly enriched, but the sets discussed here had
FDR < 0.001.
We performed GO term and KEGG pathway overrepresenta-
tion analysis on genes defined as differentially regulated using
the packageGOseq (version 1.16.2), which calculates enrichment
after correcting for transcript length bias (Young et al. 2010). GO
terms and KEGG pathways with an adjusted (Benjamini-Hoch-
berg) P-value of ≤0.05 were considered to be enriched.
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